Clinical trial Recruiting at 1 site Observational Ages 18 and up

Brain–lung interaction during sudden severe low-oxygen respiratory failure

Official title: Brain-lung Interactions in Patients Receiving High-flow Humidified Oxygen for de Novo Acute Hypoxemic Respiratory Failure

Run by Assistance Publique - Hôpitaux de Paris · NCT07279831 · Data updated 2026-11-12

We will try EEG, NIRS, and neck muscle recordings before and one hour after starting high-flow nasal oxygen in adults with sudden low-oxygen respiratory failure to see how the brain and lungs interact.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment25 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations2 sites (Paris and 1 other locations)
StatusRecruiting
StartedApril 22, 2026
Main results expectedJanuary 22, 2028
Study endsJanuary 29, 2028
Registry record updatedOctober 14, 2026
Trial IDNCT07279831 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) recently admitted to the ICU with de novo acute hypoxemic respiratory failure who are starting HFNC and are not intubated or imminently needing intubation.

Probably not a fit

Patients with exacerbations of chronic respiratory disease, indications for noninvasive ventilation, marked hypercapnia, low consciousness (GCS <13), or central neurologic disease are excluded and are unlikely to benefit from these findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study enrolling non-intubated adults admitted to the ICU with de novo acute hypoxemic respiratory failure for whom clinicians start high-flow nasal cannula (HFNC). EEG, near-infrared spectroscopy (NIRS), and scalenus muscle EMG recordings will be collected immediately before and one hour after HFNC initiation. Researchers will extract EEG spectral densities across standard frequency bands from multiple cortical regions and combine these signals with NIRS and EMG data to characterize brain–ventilation interactions. The goal is to link brain signal changes to respiratory support response and provide physiological markers that could inform future management.

Why it matters

Potential benefit: If successful, the measurements could help identify brain signatures that predict response to HFNC and potentially reduce unnecessary intubations.

How similar studies have gone: EEG and NIRS approaches have been used previously in intubated patients, but applying these combined measurements to non-intubated HFNC patients is a novel extension.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \- Age ≥ 18 years
* Admitted to the intensive care within the last 48 hours
* De novo acute hypoxemic respiratory failure with an indication for high-flow nasal cannula (HFNC), defined by the combination of the following three criteria:

  * Tachypnea \> 25 breaths/min or labored breathing
  * PaO2 (partial pressure of oxygen ) /FiO2 ( fraction of inspired oxygen ) ≤ 200 mmHg
  * Unilateral or bilateral alveolar opacities on chest X-ray
* Decision by the attending physician to initiate HFNC treatment
* After information, the patient or next of kind did not refuse to participate (according to the French law, written informed consent is waived)

Exclusion Criteria:

* \- Exacerbation of an underlying chronic respiratory disease
* Acute cardiogenic pulmonary edema indicating non-invasive ventilation (NIV)
* Hypercapnia \> 45 mmHg indicating NIV
* Glasgow Coma Scale \< 13
* Imminent intubation
* Underlying central neurological disease likely to alter EEG signals
* Pregnancy or breastfeeding
* Lack of health insurance coverage
* Patient under legal protection

Where it's running

  • Médecine Intensive - Réanimation, Hôpital Pitié Salpêtrière
    Paris, France
    Recruiting
  • Service de Médecine Intensive et Réanimation, Hôpital Pitié Salpêtrière
    Paris, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.